Boostrix Polio, Injektionssuspension

7680006810037 CH-681 Injektionssuspension
Boostrix Polio, Injektionssuspension
Boostrix Polio, Injektionssuspension
Boostrix Polio, Injektionssuspension
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
26/06/2025
Summary of Product Characteristics
Français
26/06/2025
Summary of Product Characteristics
Italien
26/06/2025

Detailed composition

Substance Quantity Type Category
toxoidum diphtheriae
- Substance Wirkstoff (Principe actif)
toxoidum tetani
- Substance Wirkstoff (Principe actif)
toxoidum pertussis
8.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum filamentosum
8.0 UG Substance Wirkstoff (Principe actif)
pertactinum
2.5 UG Substance Wirkstoff (Principe actif)
virus poliomyelitis typus 1 inactivatus
40.0 U Substance Wirkstoff (Principe actif)
virus poliomyelitis typus 2 inactivatus
8.0 U Substance Wirkstoff (Principe actif)
virus poliomyelitis typus 3 inactivatus
32.0 U Substance Wirkstoff (Principe actif)
natrii chloridum
- Substance HNIDK
natrium
1.8 MG Substance HBESI
aluminium
0.5 MG Substance HBESI
aluminii hydroxidum hydricum ad adsorptionem
- Substance HNIDK
aluminii phosphas
- Substance HNIDK
medium 199
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
neomycini sulfas
- Substance RESI
polymyxini B sulfas
- Substance RESI
polysorbatum 80
- Substance RESI
formaldehydum
- Substance RESI

Reimbursement information

Public price
CHF 41.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2004

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
681
Drug name
Boostrix Polio, Injektionssuspension
Galenic form
SUPA
ATC Code
J07CA02
Authorization status
Z
Dispensing category
B
First authorization
01/04/2004
Authorization expiration date
31/12/9999
IT Number
08.08.
Domain
Human medicine
Field of application
aktive Auffrischimpfung gegen Diphtherie, Tetanus, Pertussis und Poliomyelitis, ab dem vollendeten 4. Lebensjahr

Package details

Description (FR)
BOOSTRIX Polio susp inj (n ser pré) ser pré 0.5 ml
Description (DE)
BOOSTRIX Polio Inj Susp (n Fertspr) Fertspr 0.5 ml
Market launch
01/04/2004
Narcotic (BTM)
No

Application methods

IMU

Other package sizes (3)

BOOSTRIX Polio susp inj ser pré 0.5 ml
None None
GTIN: 7680006810013
View
BOOSTRIX Polio susp inj 10 ser pré 0.5 ml
None None
GTIN: 7680006810020
Not in V1
BOOSTRIX Polio susp inj (n ser pré) 10 x 0.5 ml
10 FESP
GTIN: 7680006810044
View
Buy us a coffee Explore the data